| 品牌 | 货号 | 包装单位 | 货期 | CAS | 产品名称 | 质量规格 | 单价(¥) | 购买数量 |
|---|---|---|---|---|---|---|---|---|
| 阿拉丁 | R126586-10mg | 10mg | 现货 | 155213-67-5 |
利托那韦 Ritonavi |
Moligand™, ≥98% |
|
|
| 阿拉丁 | R126586-50mg | 50mg | 现货 | 155213-67-5 |
利托那韦 Ritonavi |
Moligand™, ≥98% |
|
|
| 阿拉丁 | R126586-250mg | 250mg | 现货 | 155213-67-5 |
利托那韦 Ritonavi |
Moligand™, ≥98% |
|
|
| 阿拉丁 | R126586-500mg | 500mg | 现货 | 155213-67-5 |
利托那韦 Ritonavi |
Moligand™, ≥98% |
|
|
| 阿拉丁 | R408427-1ml | 1ml | 现货 | 155213-67-5 |
Ritonavir (ABT-538) Ritonavir (ABT-538) |
Moligand™, 10mM in DMSO |
|
|
| 阿拉丁 | R126586-100g | 100g | 期货,请咨询 | 155213-67-5 |
利托那韦 Ritonavi |
Moligand™, ≥98% |
|
|
| 阿拉丁 | R126586-1g | 1g | 现货 | 155213-67-5 |
利托那韦 Ritonavi |
Moligand™, ≥98% |
|
|
| 阿拉丁 | R126586-25g | 25g | 期货,请咨询 | 155213-67-5 |
利托那韦 Ritonavi |
Moligand™, ≥98% |
|
|
| 阿拉丁 | R126586-5g | 5g | 现货 | 155213-67-5 |
利托那韦 Ritonavi |
Moligand™, ≥98% |
|
|
| 梯希爱 | R0116-1G | 1G | 现货 | 155213-67-5 |
利托那韦 Ritonavi |
98.0% |
|
|
| 梯希爱 | R0116-200MG | 200MG | 现货 | 155213-67-5 |
利托那韦 Ritonavi |
98.0% |
|
|
| 阿法埃莎 | C46122-1GR | 1GR | 现货 | 155213-67-5 |
Ritonavir, 98% Ritonavir, 98% |
|
|
|
| 阿法埃莎 | C46122-250MG | 250MG | 现货 | 155213-67-5 |
Ritonavir, 98% Ritonavir, 98% |
|
|
|
| 毕得 | BD247926-100mg | 100mg | 现货 | 155213-67-5 |
N-[(2S,3S,5S)-3-羟基-5-[[(2S)-... Thiazol-5-ylmethyl ((2S,3S,5... |
98% |
|
|
| 毕得 | BD247926-250mg | 250mg | 现货 | 155213-67-5 |
N-[(2S,3S,5S)-3-羟基-5-[[(2S)-... Thiazol-5-ylmethyl ((2S,3S,5... |
98% |
|
|
| 毕得 | BD247926-1g | 1g | 现货 | 155213-67-5 |
N-[(2S,3S,5S)-3-羟基-5-[[(2S)-... Thiazol-5-ylmethyl ((2S,3S,5... |
98% |
|
|
| 毕得 | BD247926-5g | 5g | 现货 | 155213-67-5 |
N-[(2S,3S,5S)-3-羟基-5-[[(2S)-... Thiazol-5-ylmethyl ((2S,3S,5... |
98% |
|
|
| 毕得 | BD247926-25g | 25g | 现货 | 155213-67-5 |
N-[(2S,3S,5S)-3-羟基-5-[[(2S)-... Thiazol-5-ylmethyl ((2S,3S,5... |
98% |
|
|
| 毕得 | BD247926-100g | 100g | 现货 | 155213-67-5 |
N-[(2S,3S,5S)-3-羟基-5-[[(2S)-... Thiazol-5-ylmethyl ((2S,3S,5... |
98% |
|
|
| Acros | 461220010 | 1GR | 现货 | 155213-67-5 |
Ritonavir, 98% Ritonavir, 98% |
|
|